Amicus Therapeutics Inc (NASDAQ:FOLD)

7.33
BATS BZX Real-Time Price
As of 9:31am ET
 +0.04 / +0.55%
Today’s Change
5.91
Today|||52-Week Range
12.63
-36.54%
Year-to-Date
Amicus (FOLD) Q1 Earnings Miss, Galafold Sales Top Estimates
May 10 / Zacks.com - Paid Partner Content
ChemoCentryx (CCXI) Q1 Earnings and Sales Miss Estimates
May 06 / Zacks.com - Paid Partner Content
Amicus Therapeutics (FOLD) Reports Q1 Loss, Tops Revenue Estimates
May 09 / Zacks.com - Paid Partner Content
Intellia (NTLA) Q1 Loss Wider Than Expected, Revenues Beat
May 06 / Zacks.com - Paid Partner Content
Aerie (AERI) Q1 Loss Wider Than Expected, Revenues Rise Y/Y
May 06 / Zacks.com - Paid Partner Content
Why Amicus (FOLD) Might Surprise This Earnings Season
May 06 / Zacks.com - Paid Partner Content

Today’s Trading

Previous close7.29
Today’s open7.33
Day’s range7.33 - 7.33
Volume400
Average volume (3 months)3,527,218
Market cap$2.1B
Data as of 9:31am ET, 05/19/2022

Growth & Valuation

Earnings growth (last year)+13.72%
Earnings growth (this year)+7.04%
Earnings growth (next 5 years)+32.71%
Revenue growth (last year)+17.11%
P/E ratioNM
Price/Sales10.26
Price/Book6.80

Competitors

----
FHAIMicroalliance Group ...0.000.00%
CORTCorcept Therapeutics...0.000.00%
----
Data as of 4:01pm ET, 05/18/2022

Financials

Next reporting dateAugust 10, 2022
EPS forecast (this quarter)-$0.21
Annual revenue (last year)$305.5M
Annual profit (last year)-$250.5M
Net profit margin-81.98%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Major
No executives to display
Corporate headquarters
Philadelphia, Pennsylvania

Forecasts